Janet Dorling

Senior Vice President of Intercontinental Region & Global Patient Solutions, Gilead Sciences

Search every verified Janet Dorling interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Janet Dorling, Senior Vice President of the Intercontinental Region and Global Patient Solutions at Gilead Sciences, participated in a panel discussion titled "From Products to Patients: How Capital, Data, and Partnerships Unlock Growth in Asia and Africa," held as a side event to the J.P. Morgan Healthcare Conference and hosted by the Bay Area Global Health Alliance at Accenture's San Francisco Innovation Hub. During the session, she discussed Gilead's approach to creating value in high-growth markets, emphasizing that addressing opportunities in Africa and Asia requires collaboration across sectors. She stated that bringing together the right groups for conversations about patients and healthcare ecosystems has been the most valuable approach for the company. Dorling also addressed challenges related to market access, noting that Gilead aims to consider access from the start of product development, before writing a clinical protocol, based on the company's experience. She suggested that this approach, combined with bringing truly valuable innovation, has helped the company engage with government stakeholders in these regions. The broader discussion, moderated by Natasha Sunderji, explored how partnerships, financing mechanisms, and patient platforms are creating investable infrastructure in Africa and Asia, with other panelists covering topics such as health services, manufacturing, supply chain, and health technology investments.